- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
deCODE genetics Inc
DCGNQ:US
Ticker Delisted
Snapshot for deCODE genetics Inc (DCGNQ)
| Open: | - | Day's Range: | - | Volume: | 0 | Bid: | - |
|---|---|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - | Ask: | - |
Key Statistics for DCGNQ
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2009) | - |
| Earnings Per Share () (ttm) | -0.9900 |
| Est. EPS (12/2009) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 61.76 |
| Enterprise Value (M USD) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | - |
More DCGNQ Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for DCGNQ
No data available.
Company Profile & Key Executives for DCGNQ
deCODE genetics, Inc. is developing gene and drug target discovery, database, and information technology products and services for the healthcare industry using human genetics. The Company develops and applies information technology to discover new knowledge about health and disease through data-mining.
| Kari StefanssonChairman/President/CEO | Lance ThibaultCFO/Treasurer |
| Axel NielsenChief Operating Officer | Mark GurneySenior VP:Drug Discovery & Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page